 Avid Bioservices, Inc. CDMO CDMOP, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that its Board of Directors has voted to accelerate the expiration of the Companys Stockholder Rights Plan often referred to as a poison pill. Joseph Carleone, Ph.D., Avids Chairman of the Board said, Since its reconstitution in November 2017, the Board has been continuously seeking to enhance our corporate governance practices and improve long-term stockholder value. 